Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Summary

Radiation induced oral mucositis which may result in reduced quality of life is commonly seen during radiotherapy, especially combined with chemotherapy. This study is a prospective, multicenter, and exploratory study. The aim of this study is to explore predictive factors of acute radiotherapy induced oral mucositis in nasopharyngeal carcinoma patients treated with radio-chemotherapy and reduce incidence of oral mucositis by using recombinant human interleukin -11.

Timeline

Start

2018-10-01

Primary completion

2021-08-31

Completion

2022-08-30

Drugs

Indications